Agile Therapeutics Inc reports results for the quarter ended in June - Earnings Summary

Agile Therapeutics

09/08/2023 14:32

* Agile Therapeutics Inc  AGRX.OQ  reported a quarterly
adjusted
loss of $2.15​​ per share for the quarter ended in June. The
lone analyst forecast for the quarter was for a loss of $7.00
per share.
    * Revenue rose 158.8% to $5.50 million from a year ago;
analysts
expected $4.08 million. 
    * Agile Therapeutics Inc's reported EPS for the quarter was
a loss
of $2.15​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Agile Therapeutics Inc shares had fallen by 12.2% this
quarter and lost 77.2% so far this year.
    * The company reported a quarterly loss of $3.81 million.
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 9 at 01:32 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -7.00          -2.15          Beat
 Mar. 31 2023      -7.50          -5.91          Beat
 Dec. 31 2022      -11.50         -5.00          Beat
 Sep. 30 2022      -22.00         -26.50         Missed